Vimab Group AbOMXSTO: VIMAB

VIMAB: Sales up 22% year-over-year, losses narrowed, and energy segment showed strong growth

· Issued by Vimab Group AB

Net sales rose 22% year-over-year to 67.5 MSEK, with improved EBITDA and operating results. Vimab AB posted its best Q1 ever, and VIM Energy Systems expanded in battery systems and energy trading. Cash flow was negative due to high working capital.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Vimab Group Ab

All Vimab Group Ab news releases